aap Implantate Aktie
| 2,04EUR | 0,00EUR | 0,00% |
WKN DE: A3H210 / ISIN: DE000A3H2101
Personal
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Personal am Ende des Jahres | 109 | 117 | 101 | 93 | 0 |
| Umsatz pro Mitarbeiter in Mio. EUR | 0,11 | 0,10 | 0,11 | 0,13 | 0,00 |
Bilanz (in Mio. EUR) - Aktiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Umlaufvermögen | 13 | 11 | 9 | 9 | 0 |
| Summe Anlagevermögen | 10 | 10 | 11 | 7 | 0 |
| Summe Aktiva | 23 | 21 | 19 | 16 | 0 |
Bilanz (in Mio. EUR) - Passiva
| 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Summe Fremdkapital | 11 | 8 | 9 | 5 | 0 |
| Summe Eigenkapital | 13 | 13 | 11 | 10 | 0 |
| Summe Passiva | 23 | 21 | 19 | 16 | 0 |
Adresse
| Lorenzweg 5, 12099 Berlin | |
| Telefon | +49 (30) 75019-0 |
| Internet | http://aap.de |
Management
|
Jacqueline P. Rijsdijk
Vice Chairman-Supervisory Board |
|
Marc Langner
Member-Supervisory Board |
|
Nathalie Krebs
Chairman-Supervisory Board |
|
Rubino di Girolamo
Chief Executive Officer |
|
Torbjörn Sköld
Member-Supervisory Board |